SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Pulmonology Referral — Leonard Nimoy — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Leonard Nimoy |
|---|
| Date of birth | 1931-03-26 |
|---|
| Identifiers | MRN HR-ML017-SYN-TD; SSN (made up) 000-17-6604 |
|---|
| Document date | 2014-02-10 |
|---|
| Author | Carla Benedetti, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
COPD in an 82-year-old former smoker, now confirmed on spirometry as GOLD 3. Please confirm the grade and group, review the inhaler choice and the place of an inhaled corticosteroid, assess his oxygen needs, and advise on pulmonary rehabilitation and lung cancer screening. [S]
Urgency: Routine, within four weeks. [S]
Questions for the consultant:
- Do you agree with GOLD 3, group B, and is anything other than COPD contributing to his breathlessness?
- Is a long-acting bronchodilator pair in a soft mist inhaler the right start, and is there any place for an inhaled corticosteroid?
- Does he need oxygen at rest or on exertion?
- Does the alpha-1 antitrypsin level need further testing, and does he need chest CT for emphysema, lung volume reduction, or lung cancer screening?
- Should he start pulmonary rehabilitation now, and what should we watch for?
History of Present Illness
COPD diagnosed by his previous clinician without spirometry on file; he describes breathlessness that stops him after about 100 meters (mMRC 3) and uses a wheelchair at airports. CAT 22. No exacerbation, antibiotic or prednisone course, or hospital stay in the past 12 months. Smoked heavily for about 25 years (about 40 pack-years) and quit about 30 years ago; no occupational exposure. Spirometry today: post-bronchodilator FEV1 1.26 L (46 percent predicted), FVC 2.93 L, FEV1/FVC 0.43. Blood eosinophils 0.18 x10³/µL; alpha-1 antitrypsin 138 mg/dL; hemoglobin 14.6 g/dL. Resting saturation 93 percent. ECG in sinus rhythm. PHQ-9 3. Started tiotropium-olodaterol soft mist inhaler today, with albuterol as needed [S]
- Breathlessness keeps him from walking any distance, and he uses a wheelchair at airports. [S]
- Wants other smokers to quit before their lungs are damaged, and wants to keep working on his photography and writing. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Leonard Nimoy was born in Boston on March 26, 1931. [D]
- He played Mr. Spock in the Star Trek television series from 1966 to 1969, later acted in and directed Star Trek films, and directed other films, including the comedy Three Men and a Baby. [D]
- In a Twitter post at the end of January 2014 he announced that he had chronic obstructive pulmonary disease: "I quit smoking 30 yrs ago. Not soon enough. I have COPD. Grandpa says, quit now!! LLAP". [D]
- In early February 2014 he posted "I'm doing OK. Just can't walk distances," and ABC News reported that he had been seen at an airport in a wheelchair. [D]
- In February 2014 he urged smokers to quit: "Smokers, please understand. If you quit after you're diagnosed with lung damage it's too late." [D]
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Albuterol 90 mcg/actuation inhaler, two inhalations as needed for breathlessness (prescribed by his previous clinician; used once or twice most days before intake) | Two inhalations every 4 hours as needed, with a spacer | Respiratory tract route | 2013-09-15 | active | S |
| Tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations once daily | Two inhalations once each morning | Respiratory tract route | 2014-02-10 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Chronic obstructive pulmonary disease, GOLD 3 (severe airflow limitation), group B, confirmed on spirometry; synthetic modern classification linked to his publicly disclosed COPD | active | confirmed |
J44.9 | S — Synthetic modern spirometric classification; the COPD diagnosis itself is D from his own public disclosure. |
| Former smoker, quit about 30 years ago through a cessation program | active | confirmed |
Z87.891 | S — Synthetic modern entry linked to his public account of quitting smoking. |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| about 1984 | Former smoker who quit about thirty years before the index visit | D (CLM-0003) |
| January 2014 | Chronic obstructive pulmonary disease, disclosed publicly in late January, with breathlessness that keeps him from walking distances | D (CLM-0003, CLM-0004) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Former smoker: smoked cigarettes heavily for about 25 years, about 40 pack-years by his estimate, and quit about 30 years ago through a cessation program; no tobacco, vaping, or cannabis since; no alcohol; no other drug use [S]
- Actor and director, now working part time on photography, writing, and voice projects; married and lives with his spouse in a single-story home [S]
- Walks about 10 minutes at a time around the house and garden; uses a wheelchair for long distances such as airports [S]
- No occupational dust or fume exposure; no biomass or wood-stove exposure; no pets [S]
- Supports: spouse, adult children, long-time friends and colleagues; wants to use his experience to persuade smokers to quit [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2014-02-10 | Body height | 185 | cm | S |
| 2014-02-10 | Body weight | 80 | kg | S |
| 2014-02-10 | Body mass index (BMI) [Ratio] | 23.4 | kg/m2 | S |
| 2014-02-10 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2014-02-10 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2014-02-10 | Heart rate | 84 | /min | S |
| 2014-02-10 | Respiratory rate | 20 | /min | S |
| 2014-02-10 | Body temperature | 36.7 | Cel | S |
| 2014-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 93 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2014-02-10 | FEV1 --pre bronchodilation | 1.18 | L | >=1.95 L | Low | S |
| 2014-02-10 | FEV1 --post bronchodilation | 1.26 | L | >=1.95 L | Low | S |
| 2014-02-10 | FEV1 measured/predicted | 46 | % | >=80% | Low | S |
| 2014-02-10 | Forced vital capacity [Volume] Respiratory system --post bronchodilation | 2.93 | L | >=2.75 L | Normal | S |
| 2014-02-10 | FEV1/FVC --post bronchodilation | 0.43 | {ratio} | GOLD fixed ratio 0.70; post-bronchodilator ratio below 0.70 confirms airflow obstruction | Low | S |
| 2014-02-10 | Eosinophils [#/volume] in Blood by Automated count | 0.18 | 10*3/uL | 0-0.5 10*3/uL | Normal | S |
| 2014-02-10 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma | 138 | mg/dL | 90-200 mg/dL | Normal | S |
| 2014-02-10 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2014-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 2014-02-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | | | S |
Assessment
- Chronic obstructive pulmonary disease, GOLD 3 (severe airflow limitation), group B, confirmed on spirometry; synthetic modern classification linked to his publicly disclosed COPD: active, confirmed [S]
- Former smoker, quit about 30 years ago through a cessation program: active, confirmed [S]
Plan of Treatment
- Start tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations each morning, keep albuterol as needed, and teach and check inhaler technique at every visit; no inhaled corticosteroid while there are no exacerbations and blood eosinophils are below 300 per microliter. Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2025 report (2025); CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026) [S]
- At every visit: CAT, mMRC, exacerbations in the past 12 months, GOLD group, pulse oximetry, smoking status, BMI, and inhaler technique. Spirometry at diagnosis and at least yearly; alpha-1 antitrypsin once; blood eosinophils at baseline and before any change in inhaled corticosteroid; arterial blood gas only if resting saturation is 92 percent or less; long-term oxygen only for resting saturation of 88 percent or less confirmed twice at least three weeks apart; ECG and cardiovascular risk at baseline. Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2025 report (2025); CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026); Home Oxygen Therapy for Adults with Chronic Lung Disease: An Official American Thoracic Society Clinical Practice Guideline (2020) [S]
- Written COPD action plan: what an exacerbation looks like (more breathlessness, more or discolored sputum), when to use extra albuterol, and when to call the clinic the same day or go to emergency care. Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2025 report (2025); CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026) [S]
- Lung cancer screening reviewed and not offered: he quit smoking more than 15 years ago, so he does not meet the USPSTF criteria despite more than 20 pack-years. Guideline: CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026); Lung Cancer: Screening (2021) [S]
- Vaccines for COPD: yearly influenza (high dose at 65 and older), PCV20 once, RSV once at 75 and older, COVID-19 by CDC guidance, Tdap every ten years, and recombinant zoster. Guideline: CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026); Adult Immunization Schedule by Age (2026) [S]
- Comorbidity and mood screening at intake and yearly (depression, anxiety, cardiovascular disease, osteoporosis, reflux, sleep, nutrition), and advance care planning at the wellness visit. Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2025 report (2025); CMID: Clinical Monitoring Intelligence Database, chronic obstructive pulmonary disease monograph (2026) [S]
- Referral to pulmonology, Owen Rasmussen, MD, ordered 2014-02-10 [S]